Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118699183 | 11869918 | 3 | F | 20160705 | 20151228 | 20160718 | EXP | US-AUROBINDO-AUR-APL-2015-11648 | AUROBINDO | FLUOROQUINOLONE-INDUCED SERIOUS, PERSISTENT, MULTISYMPTOM ADVERSE EFFECTS.BMJ CASE REPORTS. 2015: | 55.00 | YR | F | Y | 0.00000 | 20160718 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118699183 | 11869918 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 500 MG, DAILY | U | 201043 | 500 | MG | |||||||
| 118699183 | 11869918 | 2 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 750 MG, DAILY | U | 201043 | 750 | MG | |||||||
| 118699183 | 11869918 | 3 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | UNK | U | 201043 | |||||||||
| 118699183 | 11869918 | 4 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | UNK | U | 201043 | |||||||||
| 118699183 | 11869918 | 5 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118699183 | 11869918 | 1 | Sinusitis |
| 118699183 | 11869918 | 2 | Urinary tract infection |
| 118699183 | 11869918 | 5 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118699183 | 11869918 | OT |
| 118699183 | 11869918 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118699183 | 11869918 | Affective disorder | |
| 118699183 | 11869918 | Alopecia | |
| 118699183 | 11869918 | Amnesia | |
| 118699183 | 11869918 | Anxiety | |
| 118699183 | 11869918 | Arthralgia | |
| 118699183 | 11869918 | Cognitive disorder | |
| 118699183 | 11869918 | Eye disorder | |
| 118699183 | 11869918 | Fatigue | |
| 118699183 | 11869918 | Hypoacusis | |
| 118699183 | 11869918 | Mental disorder | |
| 118699183 | 11869918 | Muscular weakness | |
| 118699183 | 11869918 | Myalgia | |
| 118699183 | 11869918 | Nervous system disorder | |
| 118699183 | 11869918 | Neuropathy peripheral | |
| 118699183 | 11869918 | Pain | |
| 118699183 | 11869918 | Respiratory muscle weakness | |
| 118699183 | 11869918 | Sensory disturbance | |
| 118699183 | 11869918 | Sleep disorder | |
| 118699183 | 11869918 | Somnolence | |
| 118699183 | 11869918 | Tendon disorder | |
| 118699183 | 11869918 | Tendon pain | |
| 118699183 | 11869918 | Tinnitus | |
| 118699183 | 11869918 | Toxicity to various agents | |
| 118699183 | 11869918 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |